アジア太平洋地域の前立腺がん診断市場、製品タイプ別（機器、試薬、消耗品、付属品）、診断タイプ別（予備スクリーニング検査、確認検査）、年齢層別（成人、小児、老年）、タイプ別（前立腺腺がん、小細胞がん、その他）、ステージ別（局所性前立腺がん、再発性/進行性前立腺がん、去勢抵抗性前立腺がん（転移性および非転移性））、サンプルタイプ別（血液、組織、尿、その他）、エンドユーザー別（独立診断研究所、病院、がん研究機関、診療所、外来手術センター、その他）、流通チャネル別（直接入札、小売販売）、国別（日本、中国、オーストラリア、韓国、インド、シンガポール、タイ、インドネシア、マレーシア、フィリピン、その他のアジア太平洋地域）業界動向と2028年までの予測
市場分析と洞察: アジア太平洋地域の前立腺がん診断市場
前立腺がん診断市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に15.1%のCAGRで成長し、2028年までに17億386万米ドルに達すると分析しています。疾患負担への注目の高まりと疾患に関する意識の高まりは、予測期間に前立腺がん診断市場を推進する主な原動力です。
前立腺がんは、前立腺の細胞が異常な速度で増殖し始めたときに始まり、その状態は前立腺がんとして知られています。前立腺は男性にのみ存在する腺です。精液の一部である液体の一部を作ります。前立腺がんの診断は、主に早期段階でがんを検出し、生存率を高めることができる将来の治療アプローチを実施する技術です。
The development of prostate cancer is closely linked with the age, with the increasing geriatric population, there is the significant increase in the incidence for prostate cancer. This will increase the demand for the diagnostics product for the detection of the disease and is expected to act as a driver for the prostate cancer diagnostics market. The PSA testing is one of the primary tests that are used for prostate cancer detection. However, the contradictions between the government and medical services provider for using PSA and related test is expected to restraint the prostate cancer diagnostics market. The market have a huge potential to grow and with the entry of new market players trying to enter market using business expansion via distribution agreements and have invested towards the prostate cancer diagnosis is expected to increase the market size and will act as opportunity for the prostate cancer diagnostics market. The barrier related with conducting the cancer diagnostics test may affect the life of the population and this is one of the most difficult part to overcome with respect to the low income countries, thus this is affecting the diagnostics community and acting as a challenge for the prostate cancer diagnostics market.
The prostate cancer diagnostics market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the prostate cancer diagnostics market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Prostate Cancer Diagnostics Market Scope and Market Size
The prostate cancer diagnostics market is categorized into eight notable segments which are based on the product type, diagnostics type, age group, type, stage, sample type, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the prostate cancer diagnostics market is segmented into instruments, reagents & consumables and accessories. In 2021, reagents & consumables segment is dominating in the prostate cancer diagnostics market as it includes the PSA testing products which is the primary test recommended for preliminary testing.
- On the basis of diagnostics type, the prostate cancer diagnostics market is segmented into preliminary screening tests and confirmatory tests. In 2021, preliminary screening tests segment is dominating in the prostate cancer diagnostics market as the number of preliminary tests surpass the number of confirmatory tests by significant percentage.
- On the basis of age group, the prostate cancer diagnostics market is segmented into adult, pediatric and geriatrics. In 2021, geriatrics segment is dominating in the prostate cancer diagnostics market as around 60% of cases are diagnosed in men over 65 year of age.
- On the basis of type, the prostate cancer diagnostics market is segmented into prostatic adenocarcinoma, small cell carcinoma and others. In 2021, prostatic adenocarcinoma segment dominates the prostate cancer diagnostics market because more than 95 percent of prostate cancers are adenocarcinomas which develop in the gland cells and line of the prostate gland.
- On the basis of stage, the prostate cancer diagnostics market is segmented into localized prostate cancer, recurrent/advanced prostate cancer and castration-resistant prostate cancer (metastatic and non-metastatic). In 2021, localized prostate cancer segment dominates the prostate cancer diagnostics market as approximately 80 percent to 85 percent of all prostate cancers are detected in the local or regional stages which represent stages I, II and III.
- On the basis of sample type, the prostate cancer diagnostics market is segmented into blood, tissue, urine and others. In 2021, blood segment is dominating the prostate cancer diagnostics market as blood is the primary sample for the most common preliminary test that is PSA test and due to easy availability of blood, less complex procedure of blood sample collection doesn’t take much time which is expected to dominate the prostate cancer diagnostics market.
- On the basis of end users, the prostate cancer diagnostics market is segmented into independent diagnostic laboratories, hospitals, cancer research institutes, clinics, ambulatory surgical centers and others. In 2021, independent diagnostic laboratories segment is dominating the prostate cancer diagnostics market as the segment is specialized in conducting various prostate cancer diagnostics.
- On the basis of distribution channel, the prostate cancer diagnostics market is segmented into direct tender and retail sales. In 2021, direct tender segment dominates the prostate cancer diagnostics market as they are the primary source of procurement of reagents, consumables, devices and accessories by healthcare organizations and diagnostic labs.
Asia-Pacific Prostate Cancer Diagnostics Market Country Level Analysis
Asia-Pacific prostate cancer diagnostics market is analysed and market size information is provided by the country, product type, diagnostics type, age group, type, stage, sample type, end users and distribution channel as referenced above.
The countries covered in the Asia-Pacific prostate cancer diagnostics market report are the Japan, China, Australia, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines and rest of Asia-Pacific.
Asia-Pacific is expected to grow with the highest CAGR in the forecasted period as in the Asia-Pacific countries, the demand for prostate cancer diagnostics product is increasing very rapidly with the urbanization. China is expected to dominate in the Asia-Pacific prostate cancer diagnostics market as China has a large population and hence the total number of tests is higher as compared to other countries in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Prostate Cancer Diagnostics Market
The prostate cancer diagnostics market also provides you with detailed market analysis for every country growth in prostate cancer diagnostics product sales, impact of advancement in the prostate cancer diagnostics and changes in regulatory scenarios with their support for the prostate cancer diagnostics market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Prostate Cancer Diagnostics Market Share Analysis
The prostate cancer diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific prostate cancer diagnostics market.
The major companies providing Asia-Pacific prostate cancer diagnostics market report are F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc., HUMASIS, Hologic Inc., Accuquik Test Kits, Abbott, Siemens Healthcare GmbH, Beckman Coulter, Inc. (a subsidiary of Danaher), Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation), bioMérieux SA, Fujirebio, Eurolyser Diagnostica GmbH among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
世界中の企業によって多くの製品の発売や契約も開始されており、前立腺がん診断市場の成長も加速しています。
例えば、
- 2021年1月、Hologic Inc.は、Biotheranostics, Inc.を2億3,000万米ドルで買収することに合意したことを発表しました。この会社は、転移性癌および乳癌の分子診断検査を提供しています。買収が完了すると、Hologic Inc.は癌患者のための世界的な腫瘍学検出で飛躍的なスタートを切り、会社の収益に貢献することになります。
市場プレーヤーによるコラボレーション、ジョイントベンチャー、その他の戦略により、前立腺がん診断市場における企業市場が強化され、組織にとっても前立腺がん診断市場への提供を改善するメリットがもたらされます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- product type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET end users coverage GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Epidemiology
- COMPARATIVE ANALYSIS WITH PARENT MARKET
- REGULATORY FRAMEWORK: ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
- REGULATORY SCENARIO IN JAPAN
- REGULATORY SCENARIO IN CHINA
- market overview
- drivers
- INCREASING PREVALENCE OF PROSTATE CANCER
- INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
- INCREASE IN GERIATRIC POPULATION
- LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
- DISEASE CAUSING PROSTATE CANCER
- RESTRAINTS
- CONTROVERSY RELATED TO PSA TESTING
- HIGH COST OF DIAGNOSTICS PROCEDURE
- LACK OF SKILLED AND CERTIFIED PROFESSIONALS
- OPPORTUNITIES
- RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
- REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
- GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS
- RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
- Challenges
- STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
- OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
- INACCURATE DIAGNOSIS RESULTS
- IMPACT OF COVID-19 ON ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
- CONCLUSION
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY product type
- overview
- reagents & consumables
- instruments
- accessories
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE
- overview
- preliminary screening tests
- Prostate-Specific Antigen (PSA) Test
- Digital Rectal Exam (DRE) Test
- Confirmatory Tests
- PCA3 Test
- biopsy
- imaging tests
- ULTRASOUND
- MAGNETIC RESONANCE IMAGING (MRI)
- MULTIPARAMETRIC MRI
- MRI FUSION-GUIDED PROSTATE BIOPSY
- CT SCAN
- BONE SCAN
- PET/CT SCAN
- biomarker
- RNA BIOMARKERS
- DNA BIOMARKERS
- PROTEIN BIOMARKERS
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By type
- overview
- PROSTATIC ADENOCARCINOMA
- small cell carcinoma
- Others
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP
- overview
- geriatrics
- adult
- Pediatric
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY Stage
- overview
- LOCALIZED PROSTATE CANCER
- RECURRENT/ADVANCED PROSTATE CANCER
- CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY sample type
- overview
- Blood
- tissue
- urine
- others
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY end users
- overview
- Independent Diagnostic Laboratories
- hospitals
- Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
- others
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY Distribution Channel
- overview
- direct tender
- retail sales
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY Country
- Asia-Pacific
- CHINA
- JAPAN
- India
- Australia
- SOUTH KOREA
- SINGAPORE
- THAILAND
- MALAYSIA
- INDONESIA
- Philippines
- REST OF Asia-Pacific
- ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY landscape
- company share analysis: Asia-Pacific
- SWOT
- company profile
- F. Hoffmann-La Roche Ltd
- COMPANY SNAPSHot
- REVENUE ANALYSIS
- product Portfoli0
- RECENT DEVELOPMENTs
- Abbott
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- siemens HEALTHCARE gmbh
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Beckman Coulter, Inc. (A Subsidiary of Danaher)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ACCUQUIK TEST KITS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- acon laboratories inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Biomerieux sa
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Eurolyser Diagnostica GmbH
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- FUJIREBIO
- COMPANY SNAPSHOT
- PRODUCT PORTFOLI
- RECENT DEVELOPMENTS
- GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HOLOGIC, INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HUMASIS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reports
表のリスト
TABLE 1 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By product type, 2019-2028 (USD Million)
TABLE 2 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By product type, 2019-2028 (UNits)
TABLE 3 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD Million)
TABLE 4 Asia-Pacific preliminary screening tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 5 Asia-Pacific Confirmatory tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 6 Asia-Pacific imaging tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 7 Asia-Pacific Magnetic Resonance Imaging (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 8 Asia-Pacific biomarker IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 9 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By type, 2019-2028 (USD million)
TABLE 10 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By age group, 2019-2028 (USD Million)
TABLE 11 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By Stage, 2019-2028 (USD Million)
TABLE 12 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By Sample Type, 2019-2028 (USD Million)
TABLE 13 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By End Users, 2019-2028 (USD Million)
TABLE 14 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 15 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)
TABLE 16 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 17 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 18 CHINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 19 CHINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 20 CHINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 21 CHINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 22 CHINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 23 CHINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 24 CHINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 25 CHINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 26 CHINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 27 CHINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 28 CHINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 29 CHINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 30 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 31 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 32 JAPAN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 33 JAPAN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 34 JAPAN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 35 JAPAN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 36 JAPAN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 37 JAPAN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 38 JAPAN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 39 JAPAN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 40 JAPAN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 41 JAPAN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 42 JAPAN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 43 JAPAN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 44 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 45 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 46 INDIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 47 INDIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 48 INDIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 49 INDIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 50 INDIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 51 INDIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 52 INDIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 53 INDIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 54 INDIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 55 INDIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 56 INDIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 57 INDIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 58 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 59 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 60 AUSTRALIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 61 AUSTRALIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 62 AUSTRALIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 63 AUSTRALIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 64 AUSTRALIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 65 AUSTRALIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 66 AUSTRALIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 67 AUSTRALIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 68 AUSTRALIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 69 AUSTRALIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 70 AUSTRALIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 71 AUSTRALIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 72 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 73 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 74 SOUTH KOREA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 75 SOUTH KOREA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 76 SOUTH KOREA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 77 SOUTH KOREA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 78 SOUTH KOREA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 79 SOUTH KOREA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 80 SOUTH KOREA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 81 SOUTH KOREA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 82 SOUTH KOREA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 83 SOUTH KOREA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 84 SOUTH KOREA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 85 SOUTH KOREA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 86 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 87 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 88 SINGAPORE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 89 SINGAPORE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 90 SINGAPORE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 91 SINGAPORE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 92 SINGAPORE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 93 SINGAPORE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 94 SINGAPORE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 95 SINGAPORE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 96 SINGAPORE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 97 SINGAPORE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 98 SINGAPORE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 99 SINGAPORE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 100 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 101 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 102 THAILAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 103 THAILAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 104 THAILAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 105 THAILAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 106 THAILAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 107 THAILAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 108 THAILAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 109 THAILAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 110 THAILAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 111 THAILAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 112 THAILAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 113 THAILAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 114 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 115 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 116 MALAYSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 117 MALAYSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 118 MALAYSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 119 MALAYSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 120 MALAYSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 121 MALAYSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 122 MALAYSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 123 MALAYSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 124 MALAYSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 125 MALAYSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 126 MALAYSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 127 MALAYSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 128 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 129 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 130 INDONESIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 131 INDONESIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 132 INDONESIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 133 INDONESIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 134 INDONESIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 135 INDONESIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 136 INDONESIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 137 INDONESIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 138 INDONESIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 139 INDONESIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 140 INDONESIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 141 INDONESIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 142 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 143 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 144 PHILIPPINES Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 145 PHILIPPINES Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 146 PHILIPPINES Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 147 PHILIPPINES Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 148 PHILIPPINES Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 149 PHILIPPINES Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 150 PHILIPPINES Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 151 PHILIPPINES Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 152 PHILIPPINES Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 153 PHILIPPINES Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 154 PHILIPPINES Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 155 PHILIPPINES Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 156 rest of Asia-Pacific Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
図表一覧
FIGURE 1 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: segmentation
FIGURE 2 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET : data triangulation
FIGURE 3 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: regional VS country MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: MARKET end users coverage GRID
FIGURE 10 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 12 INCREASING PREVALENCE OF PROSTATE CANCER, and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE Asia-Pacific prostate cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the Asia-Pacific prostate cancer diagnostics market in 2021 & 2028
FIGURE 14 REGULATORY FRAMEWORK FOR APPROVAL PROCESS IN CHINA
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
FIGURE 16 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, 2020
FIGURE 17 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, 2021-2028 (USD Million)
FIGURE 18 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, CAGR (2021-2028)
FIGURE 19 PROSTATE CANCER DIAGNOSTICS market: BY product type, LIFELINE CURVE
FIGURE 20 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, 2020
FIGURE 21 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE 2021-2028 (USD Million)
FIGURE 22 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, CAGR (2021-2028)
FIGURE 23 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, LIFELINE CURVE
FIGURE 24 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, 2020
FIGURE 25 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, 2021-2028 (USD Million)
FIGURE 26 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, CAGR (2021-2028)
FIGURE 27 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, LIFELINE CURVE
FIGURE 28 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, 2020
FIGURE 29 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group , 2021-2028 (USD Million)
FIGURE 30 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, CAGR (2021-2028)
FIGURE 31 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, LIFELINE CURVE
FIGURE 32 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, 2020
FIGURE 33 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, 2021-2028 (USD Million)
FIGURE 34 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, CAGR (2021-2028)
FIGURE 35 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, LIFELINE CURVE
FIGURE 36 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, 2020
FIGURE 37 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, 2021-2028 (USD Million)
FIGURE 38 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, CAGR (2021-2028)
FIGURE 39 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, LIFELINE CURVE
FIGURE 40 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, 2020
FIGURE 41 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, 2021-2028 (USD Million)
FIGURE 42 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, CAGR (2021-2028)
FIGURE 43 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, LIFELINE CURVE
FIGURE 44 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, 2020
FIGURE 45 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, 2021-2028 (USD Million)
FIGURE 46 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, CAGR (2021-2028)
FIGURE 47 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution, LIFELINE CURVE
FIGURE 48 Asia-Pacific Prostate cancer diagnostics market: SNAPSHOT (2020)
FIGURE 49 Asia-Pacific Prostate Cancer Diagnostics Market: BY COUNTRY (2020)
FIGURE 50 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 51 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 52 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)
FIGURE 53 Asia-Pacific Prostate cancer diagnostics market: company share 2020 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
